JP2024524458A5 - - Google Patents

Info

Publication number
JP2024524458A5
JP2024524458A5 JP2023580901A JP2023580901A JP2024524458A5 JP 2024524458 A5 JP2024524458 A5 JP 2024524458A5 JP 2023580901 A JP2023580901 A JP 2023580901A JP 2023580901 A JP2023580901 A JP 2023580901A JP 2024524458 A5 JP2024524458 A5 JP 2024524458A5
Authority
JP
Japan
Prior art keywords
cyclo
compound
bicyclo
aforementioned
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023580901A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524458A (ja
JP7696024B2 (ja
Filing date
Publication date
Priority claimed from PCT/EP2021/086674 external-priority patent/WO2023110138A1/en
Application filed filed Critical
Priority claimed from PCT/EP2022/068216 external-priority patent/WO2023275336A1/en
Publication of JP2024524458A publication Critical patent/JP2024524458A/ja
Publication of JP2024524458A5 publication Critical patent/JP2024524458A5/ja
Priority to JP2024175605A priority Critical patent/JP2025001006A/ja
Application granted granted Critical
Publication of JP7696024B2 publication Critical patent/JP7696024B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023580901A 2021-06-30 2022-06-30 トランスグルタミナーゼの阻害剤 Active JP7696024B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024175605A JP2025001006A (ja) 2021-06-30 2024-10-07 トランスグルタミナーゼの阻害剤

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
EP21182956.9 2021-06-30
EP21182956 2021-06-30
EP21183316 2021-07-01
EP21183316.5 2021-07-01
US202163217783P 2021-07-02 2021-07-02
US63/217,783 2021-07-02
EPPCT/EP2021/086674 2021-12-17
PCT/EP2021/086674 WO2023110138A1 (en) 2021-12-17 2021-12-17 Inhibitors of transglutaminases
EP2022065430 2022-06-07
EPPCT/EP2022/065430 2022-06-07
PCT/EP2022/068216 WO2023275336A1 (en) 2021-06-30 2022-06-30 Inhibitors of transglutaminases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024175605A Division JP2025001006A (ja) 2021-06-30 2024-10-07 トランスグルタミナーゼの阻害剤

Publications (3)

Publication Number Publication Date
JP2024524458A JP2024524458A (ja) 2024-07-05
JP2024524458A5 true JP2024524458A5 (cg-RX-API-DMAC7.html) 2024-08-20
JP7696024B2 JP7696024B2 (ja) 2025-06-19

Family

ID=82547318

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023580901A Active JP7696024B2 (ja) 2021-06-30 2022-06-30 トランスグルタミナーゼの阻害剤
JP2024175605A Pending JP2025001006A (ja) 2021-06-30 2024-10-07 トランスグルタミナーゼの阻害剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024175605A Pending JP2025001006A (ja) 2021-06-30 2024-10-07 トランスグルタミナーゼの阻害剤

Country Status (20)

Country Link
US (2) US20240376055A1 (cg-RX-API-DMAC7.html)
EP (1) EP4192813B1 (cg-RX-API-DMAC7.html)
JP (2) JP7696024B2 (cg-RX-API-DMAC7.html)
KR (1) KR20240028473A (cg-RX-API-DMAC7.html)
CN (1) CN117561241B (cg-RX-API-DMAC7.html)
AU (1) AU2022305117A1 (cg-RX-API-DMAC7.html)
CL (1) CL2023003979A1 (cg-RX-API-DMAC7.html)
DK (1) DK4192813T3 (cg-RX-API-DMAC7.html)
ES (1) ES2991364T3 (cg-RX-API-DMAC7.html)
FI (1) FI4192813T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20241524T1 (cg-RX-API-DMAC7.html)
HU (1) HUE068818T2 (cg-RX-API-DMAC7.html)
IL (1) IL309474A (cg-RX-API-DMAC7.html)
LT (1) LT4192813T (cg-RX-API-DMAC7.html)
MX (1) MX2023015490A (cg-RX-API-DMAC7.html)
PL (1) PL4192813T3 (cg-RX-API-DMAC7.html)
RS (1) RS66138B1 (cg-RX-API-DMAC7.html)
SI (1) SI4192813T1 (cg-RX-API-DMAC7.html)
WO (1) WO2023275336A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202400823B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL309476A (en) * 2021-06-30 2024-02-01 Zedira Gmbh Transglutaminase inhibitors
PL4192813T3 (pl) * 2021-06-30 2024-12-23 Zedira Gmbh Inhibitory transglutaminaz
DK4192812T3 (da) * 2021-06-30 2024-09-16 Zedira Gmbh Transglutaminase-inhibitorer
JP7805983B2 (ja) 2022-03-22 2026-01-26 アッヴィ・インコーポレイテッド ブルトン型チロシンキナーゼを分解するためのピリミジン

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006052755A1 (de) * 2006-11-08 2008-05-15 N-Zyme Biotec Gmbh Michaelsysteme als Transglutaminaseinhibitoren
EP2687511A1 (de) 2012-07-17 2014-01-22 Zedira GmbH Pyridinonderivate als Gewebetransglutaminaseinhibitoren
EP3342779A1 (en) * 2016-12-27 2018-07-04 Zedira GmbH Inhibitors of transglutaminases
IL309476A (en) * 2021-06-30 2024-02-01 Zedira Gmbh Transglutaminase inhibitors
PL4192813T3 (pl) * 2021-06-30 2024-12-23 Zedira Gmbh Inhibitory transglutaminaz

Similar Documents

Publication Publication Date Title
US7576095B2 (en) Therapeutic agents
JP2010540508A5 (cg-RX-API-DMAC7.html)
WO1998022432A1 (en) Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
JP2018517731A5 (cg-RX-API-DMAC7.html)
CS208112B2 (en) Method of making the new fluoralcylsubstituted derivatives of theacylanilides
JP2024541920A5 (cg-RX-API-DMAC7.html)
JP2024528557A5 (cg-RX-API-DMAC7.html)
PL200028B1 (pl) Pochodne monoazotanu izosorbidu i ich zastosowanie do wytwarzania leku o działaniu rozszerzającym naczynia krwionośne i zmniejszoną tolerancją oraz kompozycja farmaceutyczna
JP2020500205A5 (cg-RX-API-DMAC7.html)
HRP20241524T1 (hr) Inhibitori transglutaminaza
JP2015504917A (ja) Mogat−2阻害剤として有用な新規モルホリニル誘導体
JPH0610174B2 (ja) アミノフエノ−ル誘導体
EP0548680A1 (en) Beta-oxo-beta-benzenepropanethioamide derivatives
CA2502505A1 (fr) Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine
JPH01132582A (ja) テトラヒドロフランの2,4−二置換誘導体
JP5556078B2 (ja) キラル化合物の製造方法および製造中間体
JPS58201765A (ja) ジヒドロピリジン誘導体,その製造法および用途
JP2018016577A (ja) エステル化合物の製造方法
Kawashima et al. Structure-activity relationship study of TXA2 receptor antagonists. 4-[2-(4-substituted phenylsulfonylamino) ethylthio] phenoxyacetic acids and related compounds
JPH0789898A (ja) ビフェニル誘導体
FR2670780A1 (fr) Derives de 4-(acylamino)benzopyranes, leur preparation et leur application en therapeutique.
FI89599C (fi) Foerfarande foer framstaellning av terapeutiskt verksam 9,10-dihydro-4h-benso/4,5/cyklohepta/1,2-b/selenofen-9-on och -10-on
CN110724040A (zh) 碘代三氟甲氧基化合物的合成方法
JP3778521B2 (ja) シクロプロペノンアセタール誘導体の製造法
JPS6320228B2 (cg-RX-API-DMAC7.html)